(Q52691346)
Statements
Interleukin-22 immunotherapy during severe influenza enhances lung tissue integrity and reduces secondary bacterial systemic invasion. (English)
Adeline Barthelemy
Daphnée Soulard
16 April 2018
1 reference
1 reference
1 reference